Thomas Ciulla

Chief Medical Officer, Clearside Biomedical, Inc.

Companies

Viridian Therapeutics, Inc.\DEChief Medical Officer Jan 12, 2024 to Feb 7, 2024¹
Clearside Biomedical, Inc.Chief Medical Officer Jun 26, 2020 to Jan 20, 2023²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Viridian Therapeutics, Inc.\DE VRDN762 shares³$14.8K at $19.46Jan 12, 2024
Clearside Biomedical, Inc.291,890 shares⁴Jan 20, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Jan 20, 2023Sold 13,700 shares at $1.47 of Clearside Biomedical, Inc.⁴
Jan 10, 2023Sold 2,170 shares at $1.62 of Clearside Biomedical, Inc.⁵
Dec 31, 2022Granted 5,000 shares at $0.95 of Clearside Biomedical, Inc.⁶
Jun 30, 2022Granted 5,000 shares at $1.25 of Clearside Biomedical, Inc.⁶
Jan 19, 2022Sold 9,050 shares at $2.13 of Clearside Biomedical, Inc.⁷
Jan 18, 2022Granted 46,250 shares of Clearside Biomedical, Inc.⁸
Jan 18, 2022Granted 43,750 shares of Clearside Biomedical, Inc.⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARViridian Therapeutics, Inc.\DE, Chief Medical Officer
2
SEC EDGARClearside Biomedical, Inc., Chief Medical Officer
3
SEC EDGARViridian Therapeutics, Inc.\DE shares after the filing of Jan 12, 2024
4
SEC EDGARClearside Biomedical, Inc. shares after the filing of Jan 20, 2023
5
SEC EDGARForm 4 filed Jan 11, 2023
6
SEC EDGARForm 4 filed Jan 6, 2023
7
SEC EDGARForm 4 filed Jan 20, 2022
8
SEC EDGARForm 4 filed Jan 28, 2022